Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012-2013

Antiviral Research

Volumn 110, Issue 1, 2014, Pages 31-41

  Meijer, Adam ^a   Rebelo De Andrade, Helena ^b,c   Correia, Vanessa ^b,c   Besselaar, Terry ^d   Drager Dayal, Renu ^d   Fry, Alicia ^e   Gregory, Vicky ^d   Gubareva, Larisa ^e   Kageyama, Tsutomu ^d   Lackenby, Angie ^f   Lo, Janice ^g   Odagiri, Takato ^d   Pereyaslov, Dmitriy ^d   Siqueira, Marilda M ^h   Takashita, Emi ^d   Tashiro, Masato ^d   Wang, Dayan ^d   Wong, Sun ^g   Zhang, Wenqing ^d   Daniels, Rod S ^d   Hurt, Aeron C ^i,j   more..

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

^c RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f PUBLIC HEALTH ENGLAND   (United Kingdom)

^g Public Health Laboratory Center   (Hong Kong)

^h INSTITUTO OSWALDO CRUZ   (Brazil)

ⁱ VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^j UNIVERSITY OF MELBOURNE   (Australia)

more..

Author keywords

Antiviral resistance; Global analysis; Influenza virus; Neuraminidase inhibitors; Normalization using fold change data; Oseltamivir

Indexed keywords

LANINAMIVIR; OSELTAMIVIR; PERAMIVIR; SIALIDASE INHIBITOR; VIRUS SIALIDASE; ZANAMIVIR; ANTIVIRUS AGENT; CYCLOPENTANE DERIVATIVE; ENZYME INHIBITOR; GUANIDINE DERIVATIVE; SIALIDASE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIVIRAL SUSCEPTIBILITY; ARTICLE; HUMAN; IC 50; INFLUENZA VIRUS; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; NONHUMAN; PRIORITY JOURNAL; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; ANTIVIRAL RESISTANCE; DRUG EFFECTS; GENETICS; INFLUENZA VIRUS A; INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; B VICTORIA LINEAGE; B YAMAGATA LINEAGE; DISEASE PREDISPOSITION; IC50; INFLUENZA; INFLUENZA A; INFLUENZA A (H1N1); INFLUENZA A (H3N2); SEQUENCE DATABASE; VIRUS INHIBITION; WORLD HEALTH ORGANIZATION;

AMINO ACID SUBSTITUTION; ANTIVIRAL AGENTS; CYCLOPENTANES; DRUG RESISTANCE, VIRAL; ENZYME INHIBITORS; GUANIDINES; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; NEURAMINIDASE; OSELTAMIVIR; ZANAMIVIR;

HUMAN INFLUENZA VIRUS; ORTHOMYXOVIRIDAE;

EID: 84905643808     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2014.07.001     Document Type: Article

References (32)

1. Y. Abed, A. Pizzorno, X. Bouhy, and G. Boivin Role of permissive neuraminidase mutations in influenza A/Brisbane/59/2007-like (H1N1) viruses PLoS Pathog. 7 12 2011 e1002431 10.1371/journal.ppat.1002431
2. J. Butler, K.A. Hooper, S. Petrie, R. Lee, S. Maurer-Stroh, L. Reh, T. Guarnaccia, C. Baas, L. Xue, S. Vitesnik, S.K. Leang, J. McVernon, A. Kelso, I.G. Barr, J.M. McCaw, J.D. Bloom, and A.C. Hurt Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses PLoS Pathog. 10 4 2014 e1004065 10.1371/journal.ppat.1004065
3. P.J. Collins, L.F. Haire, Y.P. Lin, J. Liu, R.J. Russell, P.A. Walker, S.R. Martin, R.S. Daniels, V. Gregory, J.J. Skehel, S.J. Gamblin, and A.J. Hay Structural basis for oseltamivir resistance of influenza viruses Vaccine 27 45 2009 6317 6323 10.1016/j.vaccine.2009.07.017
4. N.J. Dharan, L.V. Gubareva, J.J. Meyer, M. Okomo-Adhiambo, R.C. McClinton, S.A. Marshall, K. St George, S. Epperson, L. Brammer, A.I. Klimov, J.S. Bresee, A.M. Fry Oseltamivir-Resistance Working Group Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States JAMA 301 10 2009 1034 1041 10.1001/jama.2009.29
5. N.J. Dharan, L.V. Gubareva, A.I. Klimov, A.E. Fiore, J.S. Bresee, and A.M. Fry Antiviral treatment of patients with oseltamivir-resistant and oseltamivir-susceptible seasonal Influenza A (H1N1) infection during the 2007-2008 influenza season in the United States Clin. Infect. Dis. 50 4 2010 621 622 10.1086/650178
6. V. Escuret, P.J. Collins, J.S. Casalegno, S.G. Vachieri, N. Cattle, O. Ferraris, M. Sabatier, E. Frobert, V. Caro, J.J. Skehel, S. Gamblin, F. Valla, M. Valette, M. Ottmann, J.W. McCauley, R.S. Daniels, and B. Lina A novel I221L substitution in neuraminidase confers high-level resistance to oseltamivir in influenza B viruses J. Infect. Dis. 2014 pii: jiu244. [Epub ahead of print]
7. J. García, M. Sovero, A.L. Torres, J. Gomez, R. Douce, M. Barrantes, F. Sanchez, M. Jimenez, G. Comach, I. de Rivera, R. Agudo, and T. Kochel Antiviral resistance in influenza viruses circulating in Central and South America based on the detection of established genetic markers Influenza Other Respir. Viruses 3 2 2009 69 74 10.1111/j.1750-2659.2009.00072.x
8. S. Garg, Z. Moore, N. Lee, J. McKenna, A. Bishop, A. Fleischauer, C.B. Springs, H.T. Nguyen, T.G. Sheu, K. Sleeman, L. Finelli, L. Gubareva, and A.M. Fry A cluster of patients infected with I221V influenza b virus variants with reduced oseltamivir susceptibility - North Carolina and South Carolina, 2010-2011 J. Infect. Dis. 207 6 2013 966 973 10.1093/infdis/jis776
9. E. Ghedin, J. Laplante, J. DePasse, D.E. Wentworth, R.P. Santos, M.L. Lepow, J. Porter, K. Stellrecht, X. Lin, D. Operario, S. Griesemer, A. Fitch, R.A. Halpin, T.B. Stockwell, D.J. Spiro, E.C. Holmes, and K. St George Deep sequencing reveals mixed infection with 2009 pandemic influenza A (H1N1) virus strains and the emergence of oseltamivir resistance J. Infect. Dis. 203 2 2011 168 174 10.1093/infdis/jiq040
10. L.V. Gubareva, A.A. Trujillo, M. Okomo-Adhiambo, V.P. Mishin, V.M. Deyde, K. Sleeman, H.T. Nguyen, T.G. Sheu, R.J. Garten, M.W. Shaw, A.M. Fry, and A.I. Klimov Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro Antiviral Ther. 15 8 2010 1151 1159 10.3851/IMP1678
11. S. Hatakeyama, N. Sugaya, M. Ito, M. Yamazaki, M. Ichikawa, K. Kimura, M. Kiso, H. Shimizu, C. Kawakami, K. Koike, K. Mitamura, and Y. Kawaoka Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors JAMA 297 13 2007 1435 1442 (Pubitemid 46556469)
12. S.H. Hauge, S. Dudman, K. Borgen, A. Lackenby, and O. Hungnes Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08 Emerg. Infect. Dis. 15 2 2009 155 162
13. A.C. Hurt, J. Ernest, Y.M. Deng, P. Iannello, T.G. Besselaar, C. Birch, P. Buchy, M. Chittaganpitch, S.C. Chiu, D. Dwyer, A. Guigon, B. Harrower, I.P. Kei, T. Kok, C. Lin, K. McPhie, A. Mohd, R. Olveda, T. Panayotou, W. Rawlinson, L. Scott, D. Smith, H. D'Souza, N. Komadina, R. Shaw, A. Kelso, and I.G. Barr Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa Antiviral Res. 83 1 2009 90 93 10.1016/j.antiviral.2009.03.003
14. A.C. Hurt, K. Hardie, N.J. Wilson, Y.M. Deng, M. Osbourn, and N. Gehrig et al. Community transmission of oseltamivir-resistant A(H1N1)pdm09 influenza N. Engl. J. Med. 365 2011 2541 2542
15. M.G. Ison, L.V. Gubareva, R.L. Atmar, J. Treanor, and F.G. Hayden Recovery of drug-resistant influenza virus from immunocompromised patients: a case series J. Infect. Dis. 193 6 2006 760 764
16. N. Kawai, H. Ikematsu, N. Hirotsu, T. Maeda, T. Kawashima, O. Tanaka, S. Yamauchi, K. Kawamura, S. Matsuura, M. Nishimura, N. Iwaki, and S. Kashiwagi Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons Clin. Infect. Dis. 49 12 2009 Dec 15 1828 1835 10.1086/648424
17. M.E. Kitler, P. Gavinio, and D. Lavanchy Influenza and the work of the World Health Organization Vaccine 20 Suppl. 2 2002 S5 S14
18. A. Lackenby, O. Hungnes, S.G. Dudman, A. Meijer, W.J. Paget, A.J. Hay, and M.C. Zambon Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe Euro Surveill. 13 5 2008 pii: 8026
19. A. Meijer, A. Lackenby, O. Hungnes, B. Lina, S. van-der-Werf, B. Schweiger, M. Opp, J. Paget, J. van-de-Kassteele, A. Hay, and M. Zambon Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season Emerg. Infect. Dis. 15 4 2009 552 560 10.3201/eid1504.181280
20. A. Meijer, M. Jonges, P. van Beek, C.M. Swaan, A.D. Osterhaus, R.S. Daniels, A.C. Hurt, and M.P. Koopmans Oseltamivir-resistant influenza A(H1N1)pdm09 virus in Dutch travellers returning from Spain, August 2012 Euro Surveill. 17 36 2012 20266
21. V.P. Mishin, F.G. Hayden, and L.V. Gubareva Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors Antimicrob. Agents Chemother. 49 11 2005 Nov 4515 4520 (Pubitemid 41552580)
22. J.É. Morlighem, S. Aoki, M. Kishima, M. Hanami, C. Ogawa, A. Jalloh, Y. Takahashi, Y. Kawai, S. Saga, E. Hayashi, T. Ban, S. Izumi, A. Wada, M. Mano, M. Fukunaga, Y. Kijima, M. Shiomi, K. Inoue, T. Hata, Y. Koretsune, K. Kudo, Y. Himeno, A. Hirai, K. Takahashi, Y. Sakai-Tagawa, K. Iwatsuki-Horimoto, Y. Kawaoka, Y. Hayashizaki, and T. Ishikawa Mutation analysis of 2009 pandemic influenza A(H1N1) viruses collected in Japan during the peak phase of the pandemic PLoS One 6 4 2011 e18956 10.1371/journal.pone.0018956
23. M.I. Nelson, L. Simonsen, C. Viboud, M.A. Miller, and E.C. Holmes The origin and global emergence of adamantane resistant A/H3N2 influenza viruses Virology 388 2 2009 270 278 10.1016/j.virol.2009.03.026
24. M. Okomo-Adhiambo, H.T. Nguyen, K. Sleeman, T.G. Sheu, V.M. Deyde, R.J. Garten, X. Xu, M.W. Shaw, A.I. Klimov, and L.V. Gubareva Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses Antiviral Res. 85 2 2010 381 388 10.1016/j.antiviral.2009.11. 005
25. M. Potier, L. Mameli, M. Bélisle, L. Dallaire, and S.B. Melançon Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate Anal. Biochem. 94 2 1979 Apr 15 287 296 (Pubitemid 9173017)
26. M.A. Rameix-Welti, S. Munier, S. Le Gal, F. Cuvelier, F. Agou, V. Enouf, N. Naffakh, and S. van der Werf Neuraminidase of 2007-2008 influenza A(H1N1) viruses shows increased affinity for sialic acids due to the D344N substitution Antiviral Ther. 16 4 2011 597 603 10.3851/IMP1804
27. T.G. Sheu, V.M. Deyde, M. Okomo-Adhiambo, R.J. Garten, X. Xu, R.A. Bright, E.N. Butler, T.R. Wallis, A.I. Klimov, and L.V. Gubareva Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008 Antimicrob. Agents Chemother. 52 9 2008 3284 3292 10.1128/AAC.00555-08
28. L. Simonsen, C. Viboud, B.T. Grenfell, J. Dushoff, L. Jennings, M. Smit, C. Macken, M. Hata, J. Gog, M.A. Miller, and E.C. Holmes The genesis and spread of reassortment human influenza A/H3N2 viruses conferring adamantane resistance Mol. Biol. Evol. 24 8 2007 1811 1820 (Pubitemid 47236702)
29. T.M. Souza, P.C. Resende, N. Fintelman-Rodrigues, T.S. Gregianini, N. Ikuta, S.B. Fernandes, A.L. Cury, C. Rosa Mdo, and M.M. Siqueira Detection of oseltamivir-resistant pandemic influenza A(H1N1)pdm2009 in Brazil: can community transmission be ruled out? PLoS One 8 11 2013 e80081 10.1371/journal.pone. 0080081
30. M. Tisdale Influenza M2 Ion-channel and neuraminidase inhibitors D.L. Mayers, S.A. Lerner, M. Ouellette, J.D. Sobel, Antimicrobial Drug Resistance, Volume 1, Mechanisms of Drug Resistance 2009 Springer Dordrecht, Heidelberg, London, New York 421 447
31. World Health Organization Meetings of the WHO working group on surveillance of influenza antiviral susceptibility - Geneva, November 2011 and June 2012 Wkly. Epidemiol. Rec. 87 39 2012 369 374
32. World Health Organization Meeting of the WHO expert working group on surveillance of influenza antiviral susceptibility, Geneva, July 2013 Wkly. Epidemiol. Rec. 88 44/45 2013 477 482